Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms
The prediction models established in this study demonstrate good predictive capability and can be used to identify patients who may benefit from ACT.
Authors
- Hengchao Liu
- Zhimin Geng (ORCID: https://orcid.org/0000-0003-2645-9808)
- Zhenqi Tang
- Qi Li (ORCID: https://orcid.org/0000-0002-8430-4778)
- Dong Zhang (ORCID: https://orcid.org/0000-0001-8254-7568)
- Yubo Ma
- Chen Chen (ORCID: https://orcid.org/0000-0002-0131-3303)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-06-06
- DOI
- https://doi.org/10.3389/fonc.2025.1594200
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China